Citations

Showing 10 of 108152 citations.

Minimal clinically important difference is lower for carpal tunnel syndrome patients undergoing injection versus surgery
Schrier, Verena J.M.M. , Gelfman, Russell , Amadio, Peter C. , Schrier, Verena Jmm

Mayo Clinic

Journal of Hand Surgery (European Volume) | September 5, 2019 | Volume: 45 | Issue: 1 | Pages: 90-92

10.1177/1753193419871631 | PMID 31488006 Get It

Cognitive function after surgery with regional or general anesthesia: A population‐based study
Schulte, Phillip J. , Petersen, Ronald C. , Martin, David P. , Hanson, Andrew C. , Schroeder, Darrell R. , Schroeder, Darrell , Šprung, Juraj , Knopman, David S. , Mielke, Michelle M. , Weingarten, Toby N. , Warner, David O.

Mayo Clinic

Alzheimer's & Dementia | September 5, 2019 | Volume: 15 | Issue: 10 | Pages: 1243-1252

10.1016/j.jalz.2019.06.4949 | PMID 31495602 Get It

AbstractIntroductionOur aim was to examine whether surgery with regional anesthesia (RA) is associated with accelerated long‐term cognitive decline comparable with that previously reported after general anesthesia (GA).MethodsLongitudinal cognitive function was analyzed in a cohort of 1819 older adults. Models assessed the rate of change in global and domain‐specific cognition over time in participants exposed to RA or GA.ResultsWhen compared with those unexposed to anesthesia, the postoperative rate of change of the cognitive global z‐score was greater in those exposed to both RA (difference in annual decline of −0.041, P = .011) and GA (−0.061, P < .001); these rates did not differ. In analysis of the domain‐specific scores, an accelerated decline in memory was observed after GA (−0.065, P < .001) but not RA (−0.011, P = .565).ConclusionsOlder adults undergoing surgery with RA experience decline of global cognition similar to those receiving GA; however, memory was not affected.
The syringe potentiometer: a low-cost device for pneumotachograph calibration
Cross, Troy J. , Kelley, Eli F. , Hardy, Tim A. , Isautier, Jennifer , Johnson, Bruce D. , Isautier, Jennifer M J, Cross, Troy James

Mayo Clinic

Journal of Applied Physiology | September 5, 2019 | Volume: 127 | Issue: 4 | Pages: 1150-1162

10.1152/japplphysiol.00150.2019 | PMID 31487222 Get It

The purpose of this report was to 1) detail the construction of a low-cost device that provides a “reference” flow waveform for pneumotachograph (PNT) calibration, i.e., the “syringe potentiometer” (SP), and to compare the 2) accuracy and 3) practical performance of “calibration curves” obtained with the SP device to other more established methods of PNT calibration, i.e., the weighted averaging (WA) and polynomial least-squares (PolyLS) methods. Volume and flow waveforms obtained via the SP device were validated against a motion capture system and were deemed accurate surrogates of actual syringe volume and flows. The SP device was used to construct a calibration curve of a PNT by dividing the flow waveform of the SP by the analog output of the PNT amplifier. A total of 187 inspiratory and 187 expiratory strokes were collected. When the entire data set of expiratory strokes was used, the SP, WA, and PolyLS methods together demonstrated acceptable volume and flow errors as per American Thoracic Society/European Respiratory Society recommendations (less than ±3.5% and less than ±5.0% errors, respectively). The “practical” performance of each method was assessed with a nested subsampling procedure, whereby volume and flow errors were evaluated as the number of strokes was increased (in blocks of 5 strokes). To this end, the SP method demonstrated practical performance superior to that of the WA and PolyLS approaches, whereby acceptable volume and flow errors were achieved after only 5 calibration strokes; the WA and PolyLS methods required 15 and 20 strokes, respectively, to achieve the same level of volume and flow accuracy.NEW & NOTEWORTHY This report describes the construction and validation of a low-cost device for the purposes of pneumotachograph (PNT) calibration: the “syringe potentiometer” (SP). Calibration of a PNT with the SP device yielded acceptable volume and flow errors (<3.5% and 5%, respectively) across a wide range of flows (<0.5 to 15 L/s). The SP device offered superior “practical performance” over other established PNT calibration methods, whereby acceptable volume and flow errors were achieved after only five calibration strokes.
PMBL: flying under the immune radar
Rimsza, Lisa M.

Mayo Clinic

Blood | September 5, 2019 | Volume: 134 | Issue: 10 | Pages: 788-789

10.1182/blood.2019002493 | PMID 31488455 Get It

POD24 in MZL: a means to an end or an end point in itself?
Maurer, Matthew J. , Maurer, Matthew

Mayo Clinic

Blood | September 5, 2019 | Volume: 134 | Issue: 10 | Pages: 787-788

10.1182/blood.2019002305 | PMID 31488454 Get It

Malingering, conversion and factitious disorders. The emotional and monetary costs to the healthcare delivery system
Pasha, Ahmed K. , Sharma, Manish

Mayo Clinic

Journal of Community Hospital Internal Medicine Perspectives | September 5, 2019 | Volume: 9 | Issue: 4 | Pages: 369-370

10.1080/20009666.2019.1643221 | PMID 31528295 Get It

Faculty Opinions recommendation of Immunotherapy in Parkinson's disease: Current status and future directions.
Caviness, John N.

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | September 5, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.736503896.793564544 Get It

Joint Pain and Proteinuria
Saleh, Abdullah S. Al , Al Saleh, Abdullah S , Sidiqi, M Hasib , Gertz, Morie A.

Mayo Clinic

JAMA | September 5, 2019 | Volume: 322 | Issue: 15 | Pages: 1512

10.1001/jama.2019.12704 | PMID 31486835 Get It

Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology
Benson, Al B. , Al-Hawary, Mahmoud M. , Arain, Mustafa A., Chen, Yi‐Jen , Ciombor, Kristen K. , Cooper, Harry S. , Deming, Dustin A. , Garrido‐Laguna, Ignacio , Grem, Jean L. , Hoffe, Sarah E. , Hunt, Steven R., Kamel, Ahmed, Kirilcuk, Natalie, Krishnamurthi, Smitha , Messersmith, Wells A. , Meyerhardt, Jeffrey A. , Miller, Eric D. , Mulcahy, Mary F. , Nurkin, Steven, Overman, Michael J. , Parikh, Aparna, Patel, Hitendra , Pedersen, Katrina S. , Shibata, David , Skibber, John M., Sofocleous, Constantinos T. , Stotsky‐Himelfarb, Eden, Willett, Christopher G. , Johnson-Chilla, Alyse, Gregory, Kristina M., Gurski, Lisa A., Hubbard, Joleen, Miller, Eric D. , Meyerhardt, Jeffrey A , Pedersen, Katrina , Venook, Alan P. , Cohen, Stacey A. , Hubbard, Joleen M. , Patel, Hitendra, Saltz, Leonard B. , Schneider, Charles John , Stoffel, Elena M.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | September 5, 2019 | Volume: 17 | Issue: 9 | Pages: 1109-1133

10.6004/jnccn.2019.0043 | PMID 31487687 Get It

Small bowel adenocarcinoma (SBA) is a rare malignancy of the gastrointestinal tract that has increased in incidence across recent years. Often diagnosed at an advanced stage, outcomes for SBA are worse on average than for other related malignancies, including colorectal cancer. Due to the rarity of this disease, few studies have been done to direct optimal treatment, although recent data have shown that SBA responds to treatment differently than colorectal cancer, necessitating a separate approach to treatment. The NCCN Guidelines for Small Bowel Adenocarcinoma were created to establish an evidence-based standard of care for patients with SBA. These guidelines provide recommendations on the workup of suspected SBA, primary treatment options, adjuvant treatment, surveillance, and systemic therapy for metastatic disease. Additionally, principles of imaging and endoscopy, pathologic review, surgery, radiation therapy, and survivorship are described.